Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    Genesis Research Group logo

    Genesis Research Group

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

    View Profile

    Market access, Regulatory affairs, Research and development

    Company Details

    Volt Pharma Associates
    Engesserstrasse 4B, Freiburg, 79114, Germany
    +49 172 6340202
    Contact Volt Pharma Associates
    Website

     Latest Content from PMHub 

    INTRODUCING SCIRIS

    Press Releases | December 5, 2022 | Porterhouse Medical Group

    imc group reveals new brand identity

    How to Increase Engagement During Virtual Events

    Videos and Podcasts | December 1, 2022 | Impetus Digital

    Tip #2 - Are you team ""jump on a call"" or team ""just email me""? Instead of choosing just one, try using a combination of synchronous (real-time) and asynchronous (over-time,...

    FREE WEBINAR: End-to-end patient strategy: making a treatment for patients, with patients

    Press Releases | November 30, 2022 | Origins – The Patient Focused Specialists

    Origins announces the first speaker on the panel of our upcoming webinar

    DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE

    Press Releases | November 30, 2022 | Medscape Education

    During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...

    OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member

    Press Releases | November 28, 2022 | OPEN Health

    OPEN Health has announced additions to its board of directors, appointing David P. King as non-executive Chairman and Paul Carter as an independent board member.

    Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence

    Press Releases | November 28, 2022 | Bedrock Healthcare Communications

    Recognition for a bold and imaginative approach to an actionable clinical consensus for MS patients.

    How To Tell A Better Silent Story

    White Papers and Resources | November 28, 2022 | The Good Ideas Group

    They say a picture's worth 1,000 words, which is incredibly helpful when telling a silent story.

    How the Legally Blind Can Achieve Enhanced Vision

    Videos and Podcasts | November 24, 2022 | Impetus Digital

    Roland Mattern, Director of Product Marketing at eSight Eyewear, shares how eSight’s technologies are being used to bring sight back to people living with central vision loss. He also discusses...

    Medscape Medical Affairs Celebrate a Double Win at the PMEAs

    Press Releases | November 24, 2022 | Medscape Medical Affairs

    Last night the Medscape Medical Affairs team gathered in London for the Pharmaceutical Market Excellence Awards (PMEAs) where their entry, Transatlantic Exchanges: Driving Therapeutic Innovation in Oncology for the Benefit of...

    Kate Shaw reflects on Innovative Trials’ first US office openings

    White Papers and Resources | November 24, 2022 | Innovative Trials

    On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening